Sign In
Buy ATRC
$26.20
+0.340 (+1.31%)
At Close: Jun 03, 2026
Envestnet Asset Management Inc. Buys Shares of 10,085 AtriCure Inc. (NASDAQ:ATRC)
06:34am, Wednesday, 05'th Aug 2020
Envestnet Asset Management Inc. purchased a new stake in AtriCure Inc. (NASDAQ:ATRC) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional inve
Analysts Anticipate AtriCure Inc. (NASDAQ:ATRC) Will Announce Quarterly Sales of $48.16 Million
01:56am, Wednesday, 05'th Aug 2020
Wall Street brokerages forecast that AtriCure Inc. (NASDAQ:ATRC) will report sales of $49.76 million for the current quarter, according to Zacks. Five analysts have provided estimates for AtriCure’s
AtriCure Inc. (ATRC): Were Hedge Funds Right About Buying This Stock?
12:55pm, Monday, 03'rd Aug 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
Piper Sandler Equities Analysts Increase Earnings Estimates for AtriCure Inc. (NASDAQ:ATRC)
02:50am, Sunday, 02'nd Aug 2020
AtriCure Inc. (NASDAQ:ATRC) – Investment analysts at Piper Sandler upped their FY2020 earnings per share estimates for AtriCure in a research report issued on Tuesday, July 28th. Piper Sandler analy
AtriCure Inc. (NASDAQ:ATRC) Forecasted to Earn Q3 2020 Earnings of ($0.29) Per Share
01:56am, Sunday, 02'nd Aug 2020
AtriCure Inc. (NASDAQ:ATRC) – Equities research analysts at SVB Leerink issued their Q3 2020 EPS estimates for shares of AtriCure in a research report issued to clients and investors on Wednesday, J
U.S. IPO Week Ahead: Rocket Companies Shoots For The Moon In A 6-IPO Week
11:36am, Saturday, 01'st Aug 2020
Six IPOs and one SPAC are scheduled to raise $4.6 billion in the week ahead, with Rocket Mortgage parent Rocket Companies slated to complete the year's largest US IPO to date.
Analysts Have Made A Financial Statement On AtriCure, Inc.'s (NASDAQ:ATRC) Second-Quarter Report
10:39am, Thursday, 30'th Jul 2020
AtriCure, Inc. (NASDAQ:ATRC) defied analyst predictions to release its second-quarter results, which were ahead of...
AtriCure to Participate at Upcoming Investor Conferences
12:00pm, Wednesday, 29'th Jul 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participat
AtriCure Inc (ATRC) Q2 2020 Earnings Call Transcript
09:01am, Wednesday, 29'th Jul 2020
Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time-to-time in AtriCure's SEC
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
AtriCure, Inc. (ATRC) CEO Mike Carrel on Q2 2020 Results - Earnings Call Transcript
09:45pm, Tuesday, 28'th Jul 2020
AtriCure, Inc. (NASDAQ:ATRC) Q2 2020 Earnings Conference Call July 28, 2020 4:30 P.M.
Recap: AtriCure Q2 Earnings
08:22pm, Tuesday, 28'th Jul 2020
Shares of AtriCure (NASDAQ:ATRC) were flat in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 123.53% over the past year to ($0.38), which beat the
AtriCure Reports Second Quarter 2020 Financial Results
08:01pm, Tuesday, 28'th Jul 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced second quarter 2020 financial results.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
